Jazz Pharmaceuticals
JAZZ
#2094
Rank
HK$58.70 B
Marketcap
HK$971.01
Share price
2.02%
Change (1 day)
2.73%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): HK$3.10 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are HK$3.99 Billion. In 2023 the company made an earning of HK$2.31 Billion, an increase over its 2022 earnings that were of -HK$2.9 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$3.10 B34.16%
2023 HK$2.31 B-179.92%
2022 -HK$2.9 Billion230.37%
2021 -HK$0.88 Billion-141.02%
2020 HK$2.13 B-39.45%
2019 HK$3.53 B-14.2%
2018 HK$4.11 B20.03%
2017 HK$3.42 B-17.15%
2016 HK$4.13 B22.14%
2015 HK$3.38 B187.64%
2014 HK$1.17 B-50.79%
2013 HK$2.39 B73.63%
2012 HK$1.37 B41.69%
2011 HK$0.97 B116.61%
2010 HK$0.44 B262.77%
2009 HK$0.12 B-111.33%
2008 -HK$1.1 Billion1.31%
2007 -HK$1.08 Billion77.8%
2006 -HK$0.61 Billion36.59%
2005 -HK$0.45 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$18.59 Billion-699.99%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$16.29 B 425.95%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$98.93 B 3,093.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$3.26 B 5.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel